India is set to launch its first indigenously developed Quadrivalent Human Papillomavirus Vaccine (qHPV) against Cervical cancer with the help of the Serum Institute of India (SII) and the Department of Biotechnology (DBT) on 1st September 2022. The vaccine for Cervical cancer “CERVAVAC”, will be launched by Union Minister of State Science and Technology Jitendra Singh. The vaccine is likely to cost around 200-400 per dose.
Bank Maha Pack includes Live Batches, Test Series, Video Lectures & eBooks
As per the government data, cervical cancer ranks number 2 for most prevalent cancer in India and also accounts for one-fourth of the world’s cervical cancer deaths. Approximately 1.25 lakhs women are diagnosed with Cervical cancer and over 75 thousand females die from the disease in India. The Union government plans to target the age of 9-14 years of girls for vaccination against cervical cancer. Before the rollout of the vaccine, a sensitization program will be organized by the government to educate parents and school authorities. The government also said that CERVAVAC is an outcome of the partnership of DBT and BIRAC with the Bill and Melinda Gates Foundation.
World Basketball Day 2025 highlights the remarkable journey of basketball from a simple indoor game…
The United Nations marked the second World Meditation Day on the 21st December with a…
The Winter Solstice 2025 occurs on Sunday, December 21 marking the shortest day and longest…
The Haryana State Assembly has unanimously passed a resolution to mark the 350th martyrdom year…
Every country has something special that makes it famous around the world. Some are known…
The United States and Jordan have carried out a major military operation in Syria called…